Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center
Medical College of Wisconsin
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
Johns Hopkins All Children's Hospital
Thomas Jefferson University
New Approaches to Neuroblastoma Therapy Consortium
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
New York Medical College
Oslo University Hospital
New Approaches to Neuroblastoma Therapy Consortium
The University of Texas Health Science Center at San Antonio
Virginia Commonwealth University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Emory University
Johns Hopkins All Children's Hospital
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Columbia University
Yale University
Ohio State University Comprehensive Cancer Center
Fox Chase Cancer Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Medical College of Wisconsin
UNC Lineberger Comprehensive Cancer Center
Stanford University
University of California, San Francisco
M.D. Anderson Cancer Center
University of Virginia
Yale University
University of Michigan Rogel Cancer Center
Milton S. Hershey Medical Center
University of Rochester
M.D. Anderson Cancer Center
University Health Network, Toronto
Ohio State University Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Indiana University
University of Southern California
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
University of Colorado, Denver
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center